Bilimsel Makale Arama | NeuralCipher AI

Kaynak kaydı

Alpha-synuclein transfers from neurons to oligodendrocytes.

Reyes JF, Rey NL, Bousset L, Melki R, Brundin P, Angot E.

Glia · 2013-12-31

DOI: 10.1002/glia.22611PMID: 24382629

Europe PMC üzerinden doğrulanabilir bibliyografik kayıt.

Makale detayına git Kaynağa git ↗

Açık erişim

Enhanced ubiquitin-dependent degradation by Nedd4 protects against α-synuclein accumulation and toxicity in animal models of Parkinson's disease.

Davies SE, Hallett PJ, Moens T, Smith G, Mangano E, Kim HT, Goldberg AL, Liu JL, Isacson O, Tofaris GK.

Neurobiol Dis · 2013-12-31

DOI: 10.1016/j.nbd.2013.12.011PMID: 24388974

Europe PMC üzerinden doğrulanabilir bibliyografik kayıt.

Makale detayına git Kaynağa git ↗

Kaynak kaydı

Alimentary, my dear Watson? The challenges of enteric α-synuclein as a Parkinson's disease biomarker.

Visanji NP, Marras C, Hazrati LN, Liu LW, Lang AE.

Mov Disord · 2013-12-26

DOI: 10.1002/mds.25789PMID: 24375496

Europe PMC üzerinden doğrulanabilir bibliyografik kayıt.

Makale detayına git Kaynağa git ↗

Kaynak kaydı

Evidence that the LRRK2 ROC domain Parkinson's disease-associated mutants A1442P and R1441C exhibit increased intracellular degradation.

Greene ID, Mastaglia F, Meloni BP, West KA, Chieng J, Mitchell CJ, Gai WP, Boulos S.

J Neurosci Res · 2013-12-24

DOI: 10.1002/jnr.23331PMID: 24375786

Europe PMC üzerinden doğrulanabilir bibliyografik kayıt.

Makale detayına git Kaynağa git ↗

Kaynak kaydı

Prevalence of cancer in Parkinson's disease related to R1441G and G2019S mutations in LRRK2.

Ruiz-Martínez J, de la Riva P, Rodríguez-Oroz MC, Mondragón Rezola E, Bergareche A, Gorostidi A, Gago B, Estanga A, Larrañaga N, Sarasqueta C, López de Munain A, Martí Massó JF.

Mov Disord · 2013-12-19

DOI: 10.1002/mds.25778PMID: 24357540

Europe PMC üzerinden doğrulanabilir bibliyografik kayıt.

Makale detayına git Kaynağa git ↗

Kaynak kaydı

Alpha-synuclein in the appendiceal mucosa of neurologically intact subjects.

Gray MT, Munoz DG, Gray DA, Schlossmacher MG, Woulfe JM.

Mov Disord · 2013-12-18

DOI: 10.1002/mds.25779PMID: 24352892

Europe PMC üzerinden doğrulanabilir bibliyografik kayıt.

Makale detayına git Kaynağa git ↗

Kaynak kaydı

Prodegenerative IκBα expression in oligodendroglial α-synuclein models of multiple system atrophy.

Kragh CL, Gysbers AM, Rockenstein E, Murphy K, Halliday GM, Masliah E, Jensen PH.

Neurobiol Dis · 2013-12-17

DOI: 10.1016/j.nbd.2013.12.002PMID: 24361600

Europe PMC üzerinden doğrulanabilir bibliyografik kayıt.

Makale detayına git Kaynağa git ↗

Kaynak kaydı

Cerebrospinal fluid α-synuclein levels in Parkinson's disease--changed or unchanged?

Zetterberg H, Petzold M, Magdalinou N.

Eur J Neurol · 2013-12-16

DOI: 10.1111/ene.12326PMID: 24330157

Europe PMC üzerinden doğrulanabilir bibliyografik kayıt.

Makale detayına git Kaynağa git ↗

Kaynak kaydı

Methylation of α-synuclein and leucine-rich repeat kinase 2 in leukocyte DNA of Parkinson's disease patients.

Tan YY, Wu L, Zhao ZB, Wang Y, Xiao Q, Liu J, Wang G, Ma JF, Chen SD.

Parkinsonism Relat Disord · 2013-12-16

DOI: 10.1016/j.parkreldis.2013.12.002PMID: 24398085

Europe PMC üzerinden doğrulanabilir bibliyografik kayıt.

Makale detayına git Kaynağa git ↗

Kaynak kaydı

Zn²⁺ dyshomeostasis caused by loss of ATP13A2/PARK9 leads to lysosomal dysfunction and alpha-synuclein accumulation.

Tsunemi T, Krainc D.

Hum Mol Genet · 2013-12-13

DOI: 10.1093/hmg/ddt572PMID: 24334770

Europe PMC üzerinden doğrulanabilir bibliyografik kayıt.

Makale detayına git Kaynağa git ↗

Kaynak kaydı

Genetic deletion of the neuronal glutamate transporter, EAAC1, results in decreased neuronal death after pilocarpine-induced status epilepticus.

Lane MC, Jackson JG, Krizman EN, Rothstein JD, Porter BE, Robinson MB.

Neurochem Int · 2013-12-12

DOI: 10.1016/j.neuint.2013.11.013PMID: 24334055

Europe PMC üzerinden doğrulanabilir bibliyografik kayıt.

Makale detayına git Kaynağa git ↗

Kaynak kaydı

Genetic assessment of familial and early-onset Parkinson's disease in a Greek population.

Bozi M, Papadimitriou D, Antonellou R, Moraitou M, Maniati M, Vassilatis DK, Papageorgiou SG, Leonardos A, Tagaris G, Malamis G, Theofilopoulos D, Kamakari S, Stamboulis E, Hadjigeorgiou GM, Athanassiadou A, Michelakakis H, Papadimitriou A, Gasser T, Stefanis L.

Eur J Neurol · 2013-12-07

DOI: 10.1111/ene.12315PMID: 24313877

Europe PMC üzerinden doğrulanabilir bibliyografik kayıt.

Makale detayına git Kaynağa git ↗

Kayıtlar bilimsel kaynaklardan alınır. Bibliyografik kayıt sayısı, Türkçe çeviri veya editoryal onay sayısı değildir.

9.897 makale bulundu

Alpha-synuclein transfers from neurons to oligodendrocytes.

Enhanced ubiquitin-dependent degradation by Nedd4 protects against α-synuclein accumulation and toxicity in animal models of Parkinson's disease.

Alimentary, my dear Watson? The challenges of enteric α-synuclein as a Parkinson's disease biomarker.

Evidence that the LRRK2 ROC domain Parkinson's disease-associated mutants A1442P and R1441C exhibit increased intracellular degradation.

Prevalence of cancer in Parkinson's disease related to R1441G and G2019S mutations in LRRK2.

Alpha-synuclein in the appendiceal mucosa of neurologically intact subjects.

Prodegenerative IκBα expression in oligodendroglial α-synuclein models of multiple system atrophy.

Cerebrospinal fluid α-synuclein levels in Parkinson's disease--changed or unchanged?

Methylation of α-synuclein and leucine-rich repeat kinase 2 in leukocyte DNA of Parkinson's disease patients.

Zn²⁺ dyshomeostasis caused by loss of ATP13A2/PARK9 leads to lysosomal dysfunction and alpha-synuclein accumulation.

Genetic deletion of the neuronal glutamate transporter, EAAC1, results in decreased neuronal death after pilocarpine-induced status epilepticus.

Genetic assessment of familial and early-onset Parkinson's disease in a Greek population.

Filtreler